Tamim Sarakpi
Overview
Explore the profile of Tamim Sarakpi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weyrich M, Zewinger S, Sarakpi T, Rasper T, Kleber M, Cremer S, et al.
Eur Heart J
. 2025 Feb;
PMID: 39935193
Background And Aims: Acquired somatic mutations emerged as important drivers of adverse cardiovascular disease outcomes. Recently, mosaic loss of Y chromosome (LOY) in haematopoietic cells was identified to induce diffuse...
2.
Amini M, Frisch J, Jost P, Sarakpi T, Selejan S, Becker E, et al.
Kidney Int
. 2024 Nov;
107(3):457-475.
PMID: 39571908
Onset, progression and cardiovascular outcome of chronic kidney disease (CKD) are influenced by the concomitant sterile inflammation. The pro-inflammatory cytokine family interleukin (IL)-1 is crucial in CKD with the key...
3.
Weyrich M, Cremer S, Gerster M, Sarakpi T, Rasper T, Zewinger S, et al.
Circulation
. 2024 Jul;
150(10):746-757.
PMID: 39005209
Background: Chronic kidney disease represents one of the strongest risk factors for cardiovascular diseases, and particularly for heart failure. Despite improved pharmaceutical treatments, mortality remains high. Recently, experimental studies demonstrated...
4.
Sarakpi T, Mesic A, Speer T
Clin Kidney J
. 2023 Nov;
16(11):1845-1860.
PMID: 37915921
Chronic kidney disease (CKD) represents an independent risk factor for cardiovascular diseases (CVD). Accordingly, CKD patients show a substantial increased risk of cardiovascular mortality. Inflammation represents an important link between...
5.
Speer T, Schunk S, Sarakpi T, Schmit D, Wagner M, Arnold L, et al.
Lancet Child Adolesc Health
. 2023 Apr;
7(6):405-414.
PMID: 37119829
Background: Childhood-onset chronic kidney disease is a progressive condition that can have a major effect on life expectancy and quality. We evaluated the usefulness of the kidney tubular cell stress...
6.
Schunk S, Hermann J, Sarakpi T, Triem S, Lellig M, Hahm E, et al.
J Am Soc Nephrol
. 2021 Sep;
32(12):3146-3160.
PMID: 34588185
Background: Coexistent CKD and cardiovascular diseases are highly prevalent in Western populations and account for substantial mortality. We recently found that apolipoprotein C-3 (ApoC3), a major constituent of triglyceride-rich lipoproteins,...
7.
Schunk S, Beisswenger C, Ritzmann F, Herr C, Wagner M, Triem S, et al.
Kidney Int
. 2021 Jul;
100(5):1081-1091.
PMID: 34237325
Chronic kidney disease (CKD) represents a global public health problem with high disease related morbidity and mortality. Since CKD etiology is heterogeneous, early recognition of patients at risk for progressive...
8.
Schunk S, Triem S, Schmit D, Zewinger S, Sarakpi T, Becker E, et al.
Circulation
. 2021 Jul;
144(11):893-908.
PMID: 34192892
Background: Cardiovascular diseases and chronic kidney disease (CKD) are highly prevalent, aggravate each other, and account for substantial mortality. Both conditions are characterized by activation of the innate immune system....
9.
Schunk S, Kleber M, Marz W, Pang S, Zewinger S, Triem S, et al.
Eur Heart J
. 2021 Mar;
42(18):1742-1756.
PMID: 33748830
Aims: Inflammation plays an important role in cardiovascular disease (CVD) development. The NOD-like receptor protein-3 (NLRP3) inflammasome contributes to the development of atherosclerosis in animal models. Components of the NLRP3...